Evgen Pharma plc (EVG.L) – BUY*: First patient dosed in cancer trial Market Cap: £16m; Current Price: 22p; Target Price: 97p
17 Jan 2017
Northland Capital Partners Morning Report
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Northland Capital Partners Morning Report
Evgen Pharma Plc (EVG:LON) | 0.9 0 0.0% | Mkt Cap: 2.41m
- Published:
17 Jan 2017 -
Author:
Vadim Alexandre -
Pages:
4
Evgen Pharma plc (EVG.L) – BUY*: First patient dosed in cancer trial Market Cap: £16m; Current Price: 22p; Target Price: 97p